Monitoring treatment effects of STI-571 on gastrointestinal stromal tumors (GIST) with CT and PET: A quantitative analysis

被引：0
|
作者：
Choi, H
Faria, SC
Benjamin, RS
Podoloff, DA
Macapinlac, HA
Charnsangavej, C
机构：
来源：
RADIOLOGY | 2002年 / 225卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：583 / 583
页数：1
相关论文
共 50 条
  • [21] Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review
    Antonia Dimitrakopoulou-Strauss
    Ulrich Ronellenfitsch
    Caixia Cheng
    Leyun Pan
    Christos Sachpekidis
    Peter Hohenberger
    Thomas Henzler
    Clinical and Translational Imaging, 2017, 5 : 183 - 197
  • [22] A Single Institutional Retrospective Experience with Fdg Pet/Ct on Treatment Response and Follow-up of Gastrointestinal Stromal Tumors (Gist)
    Sen, F.
    Akpinar, A. T.
    Kumtepe, D.
    Ogur, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S387 - S388
  • [23] A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Sawaki, A
    Yamao, K
    Nakamura, T
    Suzuki, T
    Okubo, K
    Hara, K
    Kawai, H
    Yamamura, Y
    Ito, S
    Mochiduki, Y
    Ohno, R
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 329 - 333
  • [24] A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Akira Sawaki
    Kenji Yamao
    Tsuneya Nakamura
    Takashi Suzuki
    Kenji Okubo
    Kazuo Hara
    Hiroki Kawai
    Yoshitaka Yamamura
    Seiji Ito
    Yoshinari Mochiduki
    Ryuzo Ohno
    Journal of Gastroenterology, 2004, 39 : 329 - 333
  • [25] CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings
    Choi, H
    Charnsangavej, C
    Faria, SD
    Tamm, EP
    Benjamin, RS
    Johnson, MM
    Macapinlac, HA
    Podoloff, DA
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (06) : 1619 - 1628
  • [26] Giant malignant gastrointestinal stromal tumors (>10cm) -: Recurrent factors and effect of STI 571 treatment
    Hsieh, CB
    Shih, ML
    Yu, JC
    Lee, HS
    Chen, DW
    Chao, TY
    Chang, TM
    Liu, YC
    XXXIII WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS - ICS 2002, 2002, : 119 - 123
  • [27] Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST)
    Babula, Emilia
    Sikora, Aleksandra
    Sobczuk, Pawel
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (01): : 40 - 51
  • [28] The Potential Value of F-18 FDG PET in Comparison to CT in Early Prediction of Response to Imatinib (STI571) Therapy in Patients with Gastrointestinal Stromal Tumors
    Beheshti, Mohsen
    Li, Shuren
    Vali, Reza
    Schima, Wolfgang
    Dudczak, Robert
    Langsteger, Werner
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2007, 15 (02): : 34 - 42
  • [29] Evaluation of 18F-FDG-PET/CT in comparison with conventional imaging in gastrointestinal stromal tumors (GIST).
    Vlachou, F.
    Efthimiadou, R.
    Gogou, L.
    Filipi, V.
    Nikaki, A.
    Archontaki, A.
    Dalianis, K.
    Gogos, K.
    Andreou, J.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S356 - S356
  • [30] Correction to: Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review
    Antonia Dimitrakopoulou-Strauss
    Ulrich Ronellenfitsch
    Caixia Cheng
    Leyun Pan
    Christos Sachpekidis
    Peter Hohenberger
    Thomas Henzler
    Clinical and Translational Imaging, 2017, 5 : 575 - 575
12345